(News Bulletin 247) – A clearly affirmed bullish momentum on the ASSYSTEM share will invite active investors to position themselves for the purchase, within the framework of a swing trading operation.

NB: investors who followed our recommendation on this same file on March 16 will be able to keep the position, taking care to adjust the stop loss and the target according to the elements presented below.

KEY GRAPHIC ELEMENTS

Graphical analysis of ASSYSTEM stock’s daily data makes it possible to identify an uptrend in the short term as well as in the medium term, a trend reinforced by the combination of candles in “three advancing soldiers” from 07 to 09 November. The crossing of a former resistance zone that became support at 40 euros was very clear, with consecutive bullish amplification and confirmation by pullback. The 20-day moving average (in dark blue) is a dynamic level of chart support.

FORECAST

Considering the key chart factors we have mentioned, our opinion is bullish on ASSYSTEM stock in the short term.

Active investors will take a buying position on the ASSYSTEM share price at €46,800 with a target of €55,000 in sight. They will protect their capital by placing a stop at €43,900.

The News Bulletin 247 board

ASSYSTEM
Positive €46,800
Objective :
€55,000
Potential :
+17.52%
Stop:
€43,900
Resistance(s):
47,500 / 50,000 / 55,000
Medium(s):
45,000 / 41,700 / 40,000

CHART IN DAILY DATA

Graphic made from the software Prorealtime

function creatOutbrainJs() {
const creatJs = document.createElement(“script”);
creatJs.defer = true;
creatJs.src = “https://widgets.outbrain.com/outbrain.js”;
return document.body.appendChild(creatJs);
}

window.didomiOnReady = window.didomiOnReady || [];

window.didomiOnReady.push(function(Didomi) {
console.log(“Didomi ready “);

Didomi.getObservableOnUserConsentStatusForVendor(164)
.filter(function (status) { return status !== undefined })
.subscribe(function(consentStatus) {
if (consentStatus === false || consentStatus === true) {
console.log(“Didomi consent -> exécution du script outbrain “, consentStatus);
creatOutbrainJs()
}
});

});